Delaware
|
|
|
|
46-4714474
|
State or Other Jurisdiction of
Incorporation or Organization
|
|
|
|
I.R.S. Employer Identification Number
|
|
|
|
|
|
4150 International Plaza, Suite 300
Fort Worth, Texas 76109
|
|
|
|
76109
|
Address of Principal Executive Offices
|
|
|
|
Zip Code
|
|
|
(817) 928-1500
|
|
|
Registrant’s Telephone Number, Including Area Code
|
||||
|
|
|
|
|
Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report
|
Yes
|
x
|
No
|
o
|
Yes
|
x
|
No
|
o
|
Large accelerated filer
|
o
|
Non-accelerated filer
|
o
|
Accelerated filer
|
x
|
Smaller reporting company
|
x
|
Emerging growth company
|
x
|
|
|
Title of each class
|
Trading Symbol(s)
|
Name of each exchange on which registered
|
Common Shares, $0.0004 par value
|
ELVT
|
New York Stock Exchange
|
Class
|
|
Outstanding at May 6, 2020
|
Common Shares, $0.0004 par value
|
|
42,602,175
|
Part I - Financial Information
|
|||
|
Item 1.
|
Financial Statements
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
Part II - Other Information
|
|||
|
Item 1.
|
||
|
Item 1A.
|
||
|
Item 2.
|
||
|
Item 6.
|
||
•
|
our future financial performance, including our expectations regarding our revenue, cost of revenue, growth rate of revenue, cost of borrowing, credit losses, marketing costs, net charge-offs, gross profit or gross margin, operating expenses, operating margins, loans outstanding, credit quality, ability to generate cash flow and ability to achieve and maintain future profitability;
|
•
|
the effects of the outbreak of the novel coronavirus ("COVID-19") on demand for our products, our business, our financial condition and results of operations, including as a result of the expansion of our payment flexibility program to provide temporary relief to certain customers, underwriting changes we and the bank originators we support are implementing to address credit risk associated with originations during the economic crisis created by the COVID-19 pandemic, and new legislation or other governmental responses to the pandemic;
|
•
|
the availability of debt financing, funding sources and disruptions in credit markets;
|
•
|
our ability to meet anticipated cash operating expenses and capital expenditure requirements, including our plans with respect to assessing minimum cash and liquidity requirements and implementing measures to ensure that our strong liquidity position is maintained through the current economic cycle;
|
•
|
anticipated trends, growth rates, seasonal fluctuations and challenges in our business and in the markets in which we operate;
|
•
|
our ability to anticipate market needs and develop new and enhanced or differentiated products, services and mobile apps to meet those needs, and our ability to successfully monetize them;
|
•
|
our expectations with respect to trends in our average portfolio effective annual percentage rate;
|
•
|
our anticipated growth and growth strategies and our ability to effectively manage that growth;
|
•
|
our anticipated expansion of relationships with strategic partners, including banks;
|
•
|
customer demand for our product and our ability to respond to fluctuations in demand;
|
•
|
our ability to attract potential customers and retain existing customers and our cost of customer acquisition;
|
•
|
the ability of customers to repay loans;
|
•
|
interest rates and origination fees on loans;
|
•
|
the impact of competition in our industry and innovation by our competitors;
|
•
|
our ability to attract and retain necessary qualified directors, officers and employees to expand our operations;
|
•
|
our reliance on third-party service providers;
|
•
|
our access to the automated clearing house system;
|
•
|
the efficacy of our marketing efforts and relationships with marketing affiliates;
|
•
|
our anticipated direct marketing costs and spending;
|
•
|
the evolution of technology affecting our products, services and markets;
|
•
|
continued innovation of our analytics platform, including releases of new credit models;
|
•
|
our ability to prevent security breaches, disruption in service and comparable events that could compromise the personal and confidential information held in our data systems, reduce the attractiveness of the platform or adversely impact our ability to service loans;
|
•
|
our ability to detect and filter fraudulent or incorrect information provided to us by our customers or by third parties;
|
•
|
our ability to adequately protect our intellectual property;
|
•
|
our compliance with applicable local, state, federal and foreign laws;
|
•
|
our compliance with, and the effects on our business and results of operations from, current or future applicable regulatory developments and regulations, including developments or changes from the Consumer Financial Protection Bureau ("CFPB") and developments or changes in state law;
|
•
|
regulatory developments or scrutiny by agencies regulating our business or the businesses of our third-party partners;
|
•
|
public perception of our business and industry;
|
•
|
the anticipated effect on our business of litigation or regulatory proceedings to which we or our officers are a party;
|
•
|
the anticipated effect on our business of natural or man-made catastrophes;
|
•
|
the increased expenses and administrative workload associated with being a public company;
|
•
|
failure to maintain an effective system of internal controls necessary to accurately report our financial results and prevent fraud;
|
•
|
our liquidity and working capital requirements;
|
•
|
the estimates and estimate methodologies used in preparing our consolidated financial statements;
|
•
|
the utility of non-GAAP financial measures;
|
•
|
the future trading prices of our common stock and the impact of securities analysts’ reports on these prices;
|
•
|
our anticipated development and release of certain products and applications and changes to certain products;
|
•
|
our anticipated investing activity;
|
•
|
trends anticipated to continue as our portfolio of loans matures; and
|
•
|
any future repurchases under our share repurchase program, including the timing and amount of repurchases thereunder.
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands except share amounts)
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
|
|
(unaudited)
|
|
|
||||
ASSETS
|
|
|
|
|
||||
Cash and cash equivalents*
|
|
$
|
101,429
|
|
|
$
|
88,913
|
|
Restricted cash
|
|
2,190
|
|
|
2,294
|
|
||
Loans receivable, net of allowance for loan losses of $81,816 and $86,996, respectively*
|
|
516,670
|
|
|
573,677
|
|
||
Prepaid expenses and other assets*
|
|
13,038
|
|
|
11,608
|
|
||
Operating lease right of use assets
|
|
9,746
|
|
|
10,191
|
|
||
Receivable from CSO lenders
|
|
6,822
|
|
|
8,696
|
|
||
Receivable from payment processors*
|
|
9,278
|
|
|
10,651
|
|
||
Deferred tax assets, net
|
|
9,737
|
|
|
10,139
|
|
||
Property and equipment, net
|
|
49,905
|
|
|
49,989
|
|
||
Goodwill, net
|
|
6,776
|
|
|
16,027
|
|
||
Intangible assets, net
|
|
1,371
|
|
|
1,402
|
|
||
Total assets
|
|
$
|
726,962
|
|
|
$
|
783,587
|
|
|
|
|
|
|
||||
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
Accounts payable and accrued liabilities (See Note 14)*
|
|
$
|
41,179
|
|
|
$
|
45,596
|
|
Operating lease liabilities
|
|
13,790
|
|
|
14,352
|
|
||
Income taxes payable
|
|
1,174
|
|
|
—
|
|
||
Deferred revenue*
|
|
8,831
|
|
|
12,087
|
|
||
Notes payable, net (See Note 14)*
|
|
514,206
|
|
|
555,063
|
|
||
Total liabilities
|
|
579,180
|
|
|
627,098
|
|
||
COMMITMENTS, CONTINGENCIES AND GUARANTEES (Note 12)
|
|
|
|
|
||||
STOCKHOLDERS’ EQUITY
|
|
|
|
|
||||
Preferred stock; $0.0004 par value; 24,500,000 authorized shares; None issued and outstanding at March 31, 2020 and December 31, 2019.
|
|
—
|
|
|
—
|
|
||
Common stock; $0.0004 par value; 300,000,000 authorized shares; 44,508,834 and 44,445,736 issued; 43,000,499 and 43,676,826 outstanding, respectively
|
|
18
|
|
|
18
|
|
||
Additional paid-in capital
|
|
195,471
|
|
|
193,061
|
|
||
Treasury stock; at cost; 1,508,335 and 768,910 shares of common stock, respectively
|
|
(6,717
|
)
|
|
(3,344
|
)
|
||
Accumulated deficit
|
|
(40,083
|
)
|
|
(34,342
|
)
|
||
Accumulated other comprehensive (loss) income, net of tax benefit of $1,367 and $1,353, respectively*
|
|
(907
|
)
|
|
1,096
|
|
||
Total stockholders’ equity
|
|
147,782
|
|
|
156,489
|
|
||
Total liabilities and stockholders’ equity
|
|
$
|
726,962
|
|
|
$
|
783,587
|
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended
March 31, |
||||||
(Dollars in thousands, except share and per share amounts)
|
2020
|
|
2019
|
|||||
Revenues
|
|
$
|
177,455
|
|
|
$
|
189,504
|
|
Cost of sales:
|
|
|
|
|
||||
Provision for loan losses
|
|
82,753
|
|
|
87,431
|
|
||
Direct marketing costs
|
|
12,071
|
|
|
11,154
|
|
||
Other cost of sales
|
|
8,330
|
|
|
5,060
|
|
||
Total cost of sales
|
|
103,154
|
|
|
103,645
|
|
||
Gross profit
|
|
74,301
|
|
|
85,859
|
|
||
Operating expenses:
|
|
|
|
|
||||
Compensation and benefits
|
|
26,191
|
|
|
25,710
|
|
||
Professional services
|
|
9,207
|
|
|
9,699
|
|
||
Selling and marketing
|
|
1,424
|
|
|
1,846
|
|
||
Occupancy and equipment
|
|
5,749
|
|
|
5,052
|
|
||
Depreciation and amortization
|
|
4,797
|
|
|
4,266
|
|
||
Other
|
|
1,251
|
|
|
1,307
|
|
||
Total operating expenses
|
|
48,619
|
|
|
47,880
|
|
||
Operating income
|
|
25,682
|
|
|
37,979
|
|
||
Other expense:
|
|
|
|
|
||||
Net interest expense (See Note 14)
|
|
(14,195
|
)
|
|
(19,219
|
)
|
||
Foreign currency transaction (loss) gain
|
|
(812
|
)
|
|
613
|
|
||
Impairment loss
|
|
(9,251
|
)
|
|
—
|
|
||
Non-operating loss
|
|
(4,263
|
)
|
|
—
|
|
||
Total other expense
|
|
(28,521
|
)
|
|
(18,606
|
)
|
||
(Loss) income before taxes
|
|
(2,839
|
)
|
|
19,373
|
|
||
Income tax expense
|
|
2,072
|
|
|
6,015
|
|
||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
|
|
|
|
|
||||
Basic (loss) earnings per share
|
|
$
|
(0.11
|
)
|
|
$
|
0.31
|
|
Diluted (loss) earnings per share
|
|
$
|
(0.11
|
)
|
|
$
|
0.30
|
|
Basic weighted average shares outstanding
|
|
43,161,716
|
|
|
43,348,249
|
|
||
Diluted weighted average shares outstanding
|
|
43,161,716
|
|
|
43,875,410
|
|
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
|
Three Months Ended March 31,
|
||||||
2020
|
|
2019
|
||||||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
Other comprehensive (loss) income, net of tax:
|
|
|
|
|
||||
Foreign currency translation adjustment, net of tax of $(14) and $(2) for the three months ended 2020 and 2019, respectively
|
|
(2,003
|
)
|
|
665
|
|
||
Change in derivative valuation, net of tax of $0 and $(95) for the three months ended 2020 and 2019, respectively
|
|
—
|
|
|
(208
|
)
|
||
Total other comprehensive (loss) income, net of tax
|
|
(2,003
|
)
|
|
457
|
|
||
Total comprehensive (loss) income
|
|
$
|
(6,914
|
)
|
|
$
|
13,815
|
|
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands except share amounts)
|
|
Preferred Stock
|
|
Common Stock
|
|
Additional
paid-in
capital
|
|
Treasury Stock
|
|
Accumulated
deficit
|
|
Accumulated
other comprehensive income (loss) |
|
Total
|
||||||||||||||||||||||
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
|
Shares
|
|
Amount
|
||||||||||||||||||||||||||
Balances at December 31, 2018
|
|
—
|
|
|
—
|
|
|
43,329,262
|
|
|
$
|
18
|
|
|
$
|
183,244
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
(66,525
|
)
|
|
$
|
54
|
|
|
$
|
116,791
|
|
Share-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,435
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,435
|
|
||||||
Exercise of stock options
|
|
—
|
|
|
—
|
|
|
12,500
|
|
|
—
|
|
|
26
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
26
|
|
||||||
Vesting of restricted stock units
|
|
—
|
|
|
—
|
|
|
16,034
|
|
|
—
|
|
|
(4
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4
|
)
|
||||||
Tax benefit of equity issuance costs
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2
|
)
|
||||||
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency translation adjustment net of tax benefit of $2
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
665
|
|
|
665
|
|
||||||
Change in derivative valuation net of tax benefit of $95
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(208
|
)
|
|
(208
|
)
|
||||||
Net income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
13,358
|
|
|
—
|
|
|
13,358
|
|
||||||
Balances at March 31, 2019
|
|
—
|
|
|
—
|
|
|
43,357,796
|
|
|
$
|
18
|
|
|
$
|
185,699
|
|
|
—
|
|
|
$
|
—
|
|
|
$
|
(53,167
|
)
|
|
$
|
511
|
|
|
$
|
133,061
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Balances at December 31, 2019
|
|
—
|
|
|
—
|
|
|
43,676,826
|
|
|
18
|
|
|
193,061
|
|
|
768,910
|
|
|
(3,344
|
)
|
|
(34,342
|
)
|
|
1,096
|
|
|
156,489
|
|
||||||
Share-based compensation
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,775
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
2,775
|
|
||||||
Exercise of stock options
|
|
—
|
|
|
—
|
|
|
34,185
|
|
|
—
|
|
|
(51
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(51
|
)
|
||||||
Vesting of restricted stock units
|
|
—
|
|
|
—
|
|
|
28,913
|
|
|
—
|
|
|
(314
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(314
|
)
|
||||||
Comprehensive loss:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||||||||
Foreign currency translation adjustment net of tax benefit of $14
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(2,003
|
)
|
|
(2,003
|
)
|
||||||
Treasury stock reissued for RSUs vesting
|
|
—
|
|
|
—
|
|
|
188,961
|
|
|
—
|
|
|
—
|
|
|
(188,961
|
)
|
|
830
|
|
|
(830
|
)
|
|
—
|
|
|
—
|
|
||||||
Treasury stock acquired
|
|
—
|
|
|
—
|
|
|
(928,386
|
)
|
|
—
|
|
|
—
|
|
|
928,386
|
|
|
(4,203
|
)
|
|
—
|
|
|
—
|
|
|
(4,203
|
)
|
||||||
Net loss
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(4,911
|
)
|
|
—
|
|
|
(4,911
|
)
|
||||||
Balances at March 31, 2020
|
|
—
|
|
|
—
|
|
|
43,000,499
|
|
|
$
|
18
|
|
|
$
|
195,471
|
|
|
1,508,335
|
|
|
$
|
(6,717
|
)
|
|
$
|
(40,083
|
)
|
|
$
|
(907
|
)
|
|
$
|
147,782
|
|
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
Three Months Ended March 31,
|
||||||
2020
|
|
2019
|
|||||
CASH FLOWS FROM OPERATING ACTIVITIES:
|
|
|
|
||||
Net (loss) income
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
|
|
|
|
||||
Depreciation and amortization
|
4,797
|
|
|
4,266
|
|
||
Provision for loan losses
|
82,753
|
|
|
87,431
|
|
||
Share-based compensation
|
2,775
|
|
|
2,435
|
|
||
Amortization of debt issuance costs
|
174
|
|
|
180
|
|
||
Amortization of loan premium
|
1,523
|
|
|
1,553
|
|
||
Amortization of derivative assets
|
—
|
|
|
108
|
|
||
Amortization of operating leases
|
(116
|
)
|
|
128
|
|
||
Deferred income tax expense, net
|
416
|
|
|
5,737
|
|
||
Unrealized loss from foreign currency transactions
|
812
|
|
|
(613
|
)
|
||
Impairment loss
|
9,251
|
|
|
—
|
|
||
Non-operating loss
|
4,263
|
|
|
—
|
|
||
Changes in operating assets and liabilities:
|
|
|
|
||||
Prepaid expenses and other assets
|
836
|
|
|
1,657
|
|
||
Income taxes payable
|
1,639
|
|
|
—
|
|
||
Receivables from payment processors
|
1,239
|
|
|
(2,285
|
)
|
||
Receivables from CSO lenders
|
1,875
|
|
|
4,482
|
|
||
Interest receivable
|
(17,230
|
)
|
|
(15,801
|
)
|
||
State and other taxes payable
|
—
|
|
|
394
|
|
||
Deferred revenue
|
(2,811
|
)
|
|
(5,434
|
)
|
||
Accounts payable and accrued liabilities
|
(10,586
|
)
|
|
166
|
|
||
Net cash provided by operating activities
|
76,699
|
|
|
97,762
|
|
||
CASH FLOWS FROM INVESTING ACTIVITIES:
|
|
|
|
||||
Loans receivable originated or participations purchased
|
(250,227
|
)
|
|
(272,169
|
)
|
||
Principal collections and recoveries on loans receivable
|
238,734
|
|
|
256,742
|
|
||
Participation premium paid
|
(1,400
|
)
|
|
(1,205
|
)
|
||
Purchases of property and equipment
|
(5,565
|
)
|
|
(7,105
|
)
|
||
Net cash used in investing activities
|
(18,458
|
)
|
|
(23,737
|
)
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES:
|
|
|
|
|
||||
Proceeds from notes payable
|
|
$
|
6,500
|
|
|
$
|
10,000
|
|
Payments of notes payable
|
|
(46,939
|
)
|
|
(43,000
|
)
|
||
Debt issuance costs paid
|
|
(51
|
)
|
|
(2,547
|
)
|
||
Common stock repurchased
|
|
(4,203
|
)
|
|
—
|
|
||
Proceeds from stock option exercises
|
|
27
|
|
|
26
|
|
||
Taxes paid related to net share settlement of equity awards
|
|
(314
|
)
|
|
(4
|
)
|
||
Net cash (used in) provided by financing activities
|
|
(44,980
|
)
|
|
(35,525
|
)
|
||
Effect of exchange rates on cash
|
|
(849
|
)
|
|
242
|
|
||
Net increase in cash, cash equivalents and restricted cash
|
|
12,412
|
|
|
38,742
|
|
||
|
|
|
|
|
||||
Cash and cash equivalents, beginning of period
|
|
88,913
|
|
|
58,313
|
|
||
Restricted cash, beginning of period
|
|
2,294
|
|
|
2,591
|
|
||
Cash, cash equivalents and restricted cash, beginning of period
|
|
91,207
|
|
|
60,904
|
|
||
|
|
|
|
|
||||
Cash and cash equivalents, end of period
|
|
101,429
|
|
|
97,153
|
|
||
Restricted cash, end of period
|
|
2,190
|
|
|
2,493
|
|
||
Cash, cash equivalents and restricted cash, end of period
|
|
$
|
103,619
|
|
|
$
|
99,646
|
|
|
|
|
|
|
||||
Supplemental cash flow information:
|
|
|
|
|
||||
Interest paid
|
|
$
|
14,336
|
|
|
$
|
18,988
|
|
Taxes paid
|
|
$
|
85
|
|
|
$
|
—
|
|
|
|
|
|
|
||||
Non-cash activities:
|
|
|
|
|
||||
CSO fees charged-off included in Deferred revenues and Loans receivable
|
|
$
|
423
|
|
|
$
|
2,326
|
|
CSO fees on loans paid-off prior to maturity included in Receivable from CSO lenders and Deferred revenue
|
|
$
|
21
|
|
|
$
|
90
|
|
Annual membership fee included in Deferred revenues and Loans receivable
|
|
$
|
1
|
|
|
$
|
—
|
|
Reissuances of Treasury stock
|
|
$
|
830
|
|
|
$
|
—
|
|
Changes in fair value of interest rate caps
|
|
$
|
—
|
|
|
$
|
304
|
|
Tax benefit of equity issuance costs included in Additional paid-in capital
|
|
$
|
—
|
|
|
$
|
2
|
|
Leasehold improvements allowance included in Property and equipment, net
|
|
$
|
—
|
|
|
$
|
134
|
|
Operating lease right of use assets recognized
|
|
$
|
—
|
|
|
$
|
12,289
|
|
Operating lease liabilities recognized
|
|
$
|
—
|
|
|
$
|
16,008
|
|
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
|
March 31, 2020
|
|
December 31, 2019
|
||||
Property and equipment, gross
|
|
$
|
128,154
|
|
|
$
|
124,148
|
|
Accumulated depreciation and amortization
|
|
(78,249
|
)
|
|
(74,159
|
)
|
||
Property and equipment, net
|
|
$
|
49,905
|
|
|
$
|
49,989
|
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended
March 31, |
||||||
(Dollars in thousands, except share and per share amounts)
|
|
2020
|
|
2019
|
||||
Numerator (basic):
|
|
|
|
|
||||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
|
|
|
|
|
||||
Numerator (diluted):
|
|
|
|
|
||||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
|
|
|
|
|
||||
Denominator (basic):
|
|
|
|
|
||||
Basic weighted average number of shares outstanding
|
|
43,161,716
|
|
|
43,348,249
|
|
||
|
|
|
|
|
||||
Denominator (diluted):
|
|
|
|
|
||||
Basic weighted average number of shares outstanding
|
|
43,161,716
|
|
|
43,348,249
|
|
||
Effect of potentially dilutive securities:
|
|
|
|
|
||||
Employee share plans (options, RSUs and ESPP)
|
|
—
|
|
|
527,161
|
|
||
Diluted weighted average number of shares outstanding
|
|
43,161,716
|
|
|
43,875,410
|
|
||
|
|
|
|
|
||||
Basic and diluted (loss) earnings per share:
|
|
|
|
|
||||
Basic (loss) earnings per share
|
|
$
|
(0.11
|
)
|
|
$
|
0.31
|
|
Diluted (loss) earnings per share
|
|
$
|
(0.11
|
)
|
|
$
|
0.30
|
|
•
|
1,862,170 and 1,457,296 common shares issuable upon exercise of the Company's stock options; and
|
•
|
3,584,019 and 113,114 common shares issuable upon vesting of the Company's RSUs.
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Finance charges
|
|
$
|
111,135
|
|
|
$
|
110,548
|
|
CSO fees
|
|
7,341
|
|
|
13,708
|
|
||
Lines of credit fees
|
|
58,573
|
|
|
64,733
|
|
||
Other
|
|
406
|
|
|
515
|
|
||
Total revenues
|
|
$
|
177,455
|
|
|
$
|
189,504
|
|
|
|
March 31, 2020
|
||||||||||
(Dollars in thousands)
|
|
Rise and Sunny
|
|
Elastic(1)
|
|
Total
|
||||||
Current loans
|
|
$
|
309,139
|
|
|
$
|
218,408
|
|
|
$
|
527,547
|
|
Past due loans
|
|
49,084
|
|
|
19,803
|
|
|
68,887
|
|
|||
Total loans receivable
|
|
358,223
|
|
|
238,211
|
|
|
596,434
|
|
|||
Net unamortized loan premium
|
|
215
|
|
|
1,837
|
|
|
2,052
|
|
|||
Less: Allowance for loan losses
|
|
(55,763
|
)
|
|
(26,053
|
)
|
|
(81,816
|
)
|
|||
Loans receivable, net
|
|
$
|
302,675
|
|
|
$
|
213,995
|
|
|
$
|
516,670
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
December 31, 2019
|
||||||||||
(Dollars in thousands)
|
|
Rise and Sunny
|
|
Elastic(1)
|
|
Total
|
||||||
Current loans
|
|
$
|
339,816
|
|
|
$
|
243,380
|
|
|
$
|
583,196
|
|
Past due loans
|
|
52,664
|
|
|
22,395
|
|
|
75,059
|
|
|||
Total loans receivable
|
|
392,480
|
|
|
265,775
|
|
|
658,255
|
|
|||
Net unamortized loan premium
|
|
290
|
|
|
2,128
|
|
|
2,418
|
|
|||
Less: Allowance for loan losses
|
|
(57,103
|
)
|
|
(29,893
|
)
|
|
(86,996
|
)
|
|||
Loans receivable, net
|
|
$
|
335,667
|
|
|
$
|
238,010
|
|
|
$
|
573,677
|
|
|
|
Three Months Ended March 31, 2020
|
||||||||||
(Dollars in thousands)
|
|
Rise and Sunny
|
|
Elastic(1)
|
|
Total
|
||||||
Balance beginning of period
|
|
$
|
59,182
|
|
|
$
|
29,893
|
|
|
$
|
89,075
|
|
Provision for loan losses
|
|
58,747
|
|
|
24,006
|
|
|
82,753
|
|
|||
Charge-offs
|
|
(65,878
|
)
|
|
(30,314
|
)
|
|
(96,192
|
)
|
|||
Recoveries of prior charge-offs
|
|
5,660
|
|
|
2,468
|
|
|
8,128
|
|
|||
Effect of changes in foreign currency rates
|
|
(377
|
)
|
|
—
|
|
|
(377
|
)
|
|||
Total
|
|
57,334
|
|
|
26,053
|
|
|
83,387
|
|
|||
Accrual for CSO lender owned loans
|
|
(1,571
|
)
|
|
—
|
|
|
(1,571
|
)
|
|||
Balance end of period
|
|
$
|
55,763
|
|
|
$
|
26,053
|
|
|
$
|
81,816
|
|
|
|
Three Months Ended March 31, 2019
|
||||||||||
(Dollars in thousands)
|
|
Rise and Sunny
|
|
Elastic(1)
|
|
Total
|
||||||
Balance beginning of period
|
|
$
|
60,002
|
|
|
$
|
36,050
|
|
|
$
|
96,052
|
|
Provision for loan losses
|
|
57,869
|
|
|
29,562
|
|
|
87,431
|
|
|||
Charge-offs
|
|
(72,135
|
)
|
|
(39,559
|
)
|
|
(111,694
|
)
|
|||
Recoveries of prior charge-offs
|
|
5,421
|
|
|
2,288
|
|
|
7,709
|
|
|||
Effect of changes in foreign currency rates
|
|
201
|
|
|
—
|
|
|
201
|
|
|||
Total
|
|
51,358
|
|
|
28,341
|
|
|
79,699
|
|
|||
Accrual for CSO lender owned loans
|
|
(3,242
|
)
|
|
—
|
|
|
(3,242
|
)
|
|||
Balance end of period
|
|
$
|
48,116
|
|
|
$
|
28,341
|
|
|
$
|
76,457
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Outstanding recorded investment before TDR
|
|
$
|
7,546
|
|
|
$
|
12,725
|
|
Outstanding recorded investment after TDR
|
|
7,228
|
|
|
11,355
|
|
||
Total principal and interest forgiveness included in charge-offs within the Allowance for loan losses
|
|
$
|
318
|
|
|
$
|
1,370
|
|
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Current outstanding investment
|
|
$
|
10,306
|
|
|
$
|
11,559
|
|
Delinquent outstanding investment
|
|
6,290
|
|
|
7,273
|
|
||
Outstanding recorded investment
|
|
16,596
|
|
|
18,832
|
|
||
Less: Impairment included in Allowance for loan losses
|
|
(4,326
|
)
|
|
(5,238
|
)
|
||
Outstanding recorded investment, net of impairment
|
|
$
|
12,270
|
|
|
$
|
13,594
|
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
ASSETS
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
44,439
|
|
|
$
|
26,245
|
|
Loans receivable, net of allowance for loan losses of $25,145 and $28,852, respectively
|
|
209,499
|
|
|
234,504
|
|
||
Prepaid expenses and other assets
|
|
2
|
|
|
—
|
|
||
Receivable from payment processors
|
|
4,713
|
|
|
6,363
|
|
||
Total assets
|
|
$
|
258,653
|
|
|
$
|
267,112
|
|
LIABILITIES AND SHAREHOLDER’S EQUITY
|
|
|
|
|
||||
Accounts payable and accrued liabilities ($9,199 and $7,690, respectively, eliminates upon consolidation)
|
|
$
|
14,522
|
|
|
$
|
15,902
|
|
Deferred revenue
|
|
3,562
|
|
|
4,280
|
|
||
Reserve deposit liability ($23,150 and $23,150, respectively, eliminates upon consolidation)
|
|
23,150
|
|
|
23,150
|
|
||
Notes payable, net
|
|
217,419
|
|
|
223,780
|
|
||
Accumulated other comprehensive income
|
|
—
|
|
|
—
|
|
||
Total liabilities and shareholder’s equity
|
|
$
|
258,653
|
|
|
$
|
267,112
|
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
ASSETS
|
|
|
|
|
||||
Cash and cash equivalents
|
|
$
|
13,436
|
|
|
$
|
7,541
|
|
Loans receivable, net of allowance for loan losses of $21,558 and $17,436, respectively
|
|
117,998
|
|
|
111,281
|
|
||
Receivable from payment processors ($322 and $0 eliminates upon consolidation)
|
|
837
|
|
|
681
|
|
||
Total assets
|
|
$
|
132,271
|
|
|
$
|
119,503
|
|
LIABILITIES AND SHAREHOLDER’S EQUITY
|
|
|
|
|
||||
Accounts payable and accrued liabilities ($13,461 and $7,114, respectively, eliminates upon consolidation)
|
|
$
|
14,842
|
|
|
$
|
8,576
|
|
Reserve deposit liability ($8,950 and $8,950, respectively, eliminates upon consolidation)
|
|
8,950
|
|
|
8,950
|
|
||
Notes payable, net
|
|
108,479
|
|
|
101,977
|
|
||
Total liabilities and shareholder’s equity
|
|
$
|
132,271
|
|
|
$
|
119,503
|
|
Elevate Credit, Inc. and Subsidiaries
|
•
|
A maximum borrowing amount of $350 million used to fund the Rise loan portfolio (“US Term Note”). Prior to the February 1, 2019 amendment, the interest rate paid on this facility was a base rate (defined as the 3-month LIBOR, with a 1% floor) plus 11%. Upon the February 1, 2019 amendment date, the interest rate on the debt outstanding as of the amendment date was fixed through the January 1, 2024 maturity date at 10.23% (base rate of 2.73% plus 7.5%). At both December 31, 2019 and March 31, 2020, the weighted average base rate on the outstanding balance was 2.73% and the overall interest rate was 10.23%. All future borrowings under this facility will bear an interest rate at a base rate (defined as the greater of 3-month LIBOR, the five-year LIBOR swap rate or 1%) plus 7.5% at the borrowing date.
|
•
|
A maximum borrowing amount of $124 million used to fund the UK Sunny loan portfolio (“UK Term Note”). Prior to the February 1, 2019 amendment, the interest rate paid on this facility was a base rate (defined as the 3-month LIBOR) plus 14%. Upon the February 1, 2019 amendment date, the interest rate on the debt outstanding as of the amendment date was fixed through the January 1, 2024 maturity date at 10.23% (base rate of 2.73% plus 7.5%). At both December 31, 2019 and March 31, 2020, the weighted average base rate on the outstanding balance at was 2.73% and the overall interest rate was 10.23%. All future borrowings under this facility will bear an interest rate at a base rate (defined as the greater of 3-month LIBOR, the five-year LIBOR swap rate or 1%) plus 7.5% at the borrowing date.
|
•
|
A maximum borrowing amount of $18 million used to fund working capital, and prior to February 1, 2019, at a base rate (defined as the 3-month LIBOR, with a 1% floor) plus 13% (“4th Tranche Term Note”). Upon the February 1, 2019 amendment date, the interest rate was fixed through the February 1, 2021 maturity date at a base rate of 2.73% plus 13%. The interest rate at both March 31, 2020 and December 31, 2019 was 15.73%. There was no change in the interest rate spread on this facility upon the February 1, 2019 amendment.
|
•
|
Revolving feature providing the option to pay down up to 20% of the outstanding balance, excluding the 4th Tranche Term Note, once per year during the first quarter. Amounts paid down may be drawn again at a later date prior to maturity.
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
US Term Note bearing interest at the base rate + 7.5%
|
|
$
|
154,500
|
|
|
$
|
182,000
|
|
UK Term Note bearing interest at the base rate + 7.5%
|
|
16,154
|
|
|
29,635
|
|
||
4th Tranche Term Note bearing interest at the base rate + 13%
|
|
18,050
|
|
|
18,050
|
|
||
EF SPV Term Note bearing interest at the base rate + 7.5%
|
|
108,500
|
|
|
102,000
|
|
||
ESPV Term Note bearing interest at the base rate + 7.5%
|
|
219,500
|
|
|
226,000
|
|
||
Debt issuance costs
|
|
(2,498
|
)
|
|
(2,622
|
)
|
||
Total
|
|
$
|
514,206
|
|
|
$
|
555,063
|
|
•
|
US Term Note - Paydown of $27.5 million under the revolver component of the facility;
|
•
|
UK Term Note - Paydown of $12.9 million under the revolver component of the facility;
|
•
|
EF SPV Term note - Draw of $6.5 million; and
|
•
|
ESPV Term Note - Paydown of $6.5 million under the revolver component of the facility.
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
(Dollars in thousands)
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||
Assets subject to amortization:
|
|
|
|
|
|
|
||||||
Acquired technology
|
|
$
|
946
|
|
|
$
|
(946
|
)
|
|
$
|
—
|
|
Non-compete
|
|
3,404
|
|
|
(2,713
|
)
|
|
691
|
|
|||
Customers
|
|
126
|
|
|
(126
|
)
|
|
—
|
|
|||
Assets not subject to amortization:
|
|
|
|
|
|
|
||||||
Domain names
|
|
680
|
|
|
0
|
|
|
680
|
|
|||
Total
|
|
$
|
5,156
|
|
|
$
|
(3,785
|
)
|
|
$
|
1,371
|
|
(Dollars in thousands)
|
|
Cost
|
|
Accumulated
Amortization
|
|
Net
|
||||||
Assets subject to amortization:
|
|
|
|
|
|
|
||||||
Acquired technology
|
|
$
|
946
|
|
|
$
|
(946
|
)
|
|
$
|
—
|
|
Non-compete
|
|
3,404
|
|
|
(2,682
|
)
|
|
722
|
|
|||
Customers
|
|
126
|
|
|
(126
|
)
|
|
—
|
|
|||
Assets not subject to amortization:
|
|
|
|
|
|
|
||||||
Domain names
|
|
680
|
|
|
—
|
|
|
680
|
|
|||
Total
|
|
$
|
5,156
|
|
|
$
|
(3,754
|
)
|
|
$
|
1,402
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
Three Months Ended March 31,
|
|||||
Lease cost (dollars in thousands)
|
2020
|
2019
|
||||
Operating lease cost
|
$
|
808
|
|
$
|
1,148
|
|
Short-term lease cost
|
346
|
|
11
|
|
||
Total lease cost
|
$
|
1,154
|
|
$
|
1,159
|
|
|
Three Months Ended March 31,
|
|||||
Supplemental cash flows information (dollars in thousands)
|
2020
|
2019
|
||||
Cash paid for amounts included in the measurement of lease liabilities
|
$
|
924
|
|
$
|
1,020
|
|
Right-of-use assets obtained in exchange for lease obligations
|
$
|
—
|
|
$
|
—
|
|
Weighted average remaining lease term
|
4.2 years
|
|
4.7 years
|
|
||
Weighted average discount rate
|
10.23
|
%
|
10.23
|
%
|
Year (dollars in thousands)
|
Operating Leases
|
||
2020
|
$
|
2,835
|
|
2021
|
3,876
|
|
|
2022
|
3,984
|
|
|
2023
|
3,486
|
|
|
2024
|
1,438
|
|
|
Thereafter
|
1,893
|
|
|
Total future minimum lease payments
|
$
|
17,512
|
|
Less: Imputed interest
|
(3,722
|
)
|
|
Operating lease liabilities
|
$
|
13,790
|
|
Elevate Credit, Inc. and Subsidiaries
|
Stock Options
|
|
Shares
|
|
Weighted Average
Exercise Price |
|
Weighted Average Remaining Contractual Life (in years)
|
|||
Outstanding at December 31, 2019
|
|
2,269,178
|
|
|
$
|
4.58
|
|
|
|
Granted
|
|
55,161
|
|
|
3.39
|
|
|
|
|
Exercised
|
|
(87,500
|
)
|
|
2.13
|
|
|
|
|
Forfeited
|
|
(30,386
|
)
|
|
4.05
|
|
|
|
|
Outstanding at March 31, 2020
|
|
2,206,453
|
|
|
4.65
|
|
|
3.86
|
|
Options exercisable at March 31, 2020
|
|
2,091,700
|
|
|
$
|
4.69
|
|
|
3.56
|
Elevate Credit, Inc. and Subsidiaries
|
RSUs
|
|
Shares
|
|
Weighted Average
Grant-Date Fair Value |
|||
Nonvested at December 31, 2019
|
|
4,161,862
|
|
|
$
|
6.10
|
|
Granted
|
|
415,313
|
|
|
2.10
|
|
|
Vested
|
|
(297,442
|
)
|
|
4.81
|
|
|
Forfeited
|
|
(5,668
|
)
|
|
4.41
|
|
|
Nonvested at March 31, 2020
|
|
4,274,065
|
|
|
5.80
|
|
|
Expected to vest at March 31, 2020
|
|
3,413,006
|
|
|
$
|
6.00
|
|
Elevate Credit, Inc. and Subsidiaries
|
Gains recognized in Interest expense
|
|
Three Months Ended
March 31, 2020 |
|
Three Months Ended
March 31, 2019 |
||||
US Term Note interest rate cap
|
|
$
|
—
|
|
|
$
|
159
|
|
ESPV Facility interest rate cap
|
|
—
|
|
|
144
|
|
||
|
|
$
|
—
|
|
|
$
|
303
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended
March 31, 2020 |
|
Three Months Ended
March 31, 2019 |
||||||||||||
(Dollars in thousands)
|
|
US Term Note
|
|
ESPV Facility
|
|
US Term Note
|
|
ESPV Facility
|
||||||||
Beginning unrealized gains in Accumulated other comprehensive (loss) income
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
159
|
|
|
$
|
144
|
|
Gross gains recognized in Accumulated other comprehensive (loss) income
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
||||
Gains reclassified to (loss) income through Interest expense
|
|
—
|
|
|
—
|
|
|
(159
|
)
|
|
(144
|
)
|
||||
Ending unrealized gains in Accumulated other comprehensive (loss) income
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
$
|
—
|
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Current income tax expense (benefit):
|
|
|
|
|
||||
Federal
|
|
$
|
1,152
|
|
|
$
|
—
|
|
State
|
|
487
|
|
|
278
|
|
||
Foreign
|
|
17
|
|
|
—
|
|
||
Total current income tax expense
|
|
1,656
|
|
|
278
|
|
||
|
|
|
|
|
||||
Deferred income tax expense (benefit):
|
|
|
|
|
||||
Federal
|
|
73
|
|
|
4,339
|
|
||
State
|
|
343
|
|
|
1,398
|
|
||
Total deferred income tax expense
|
|
416
|
|
|
5,737
|
|
||
|
|
|
|
|
||||
Total income tax expense
|
|
$
|
2,072
|
|
|
$
|
6,015
|
|
Elevate Credit, Inc. and Subsidiaries
|
•
|
In 2019, the Company continued to grow its operating income (from $71 million in 2017 to $95 million in 2018 to $111 million in 2019). The US-only pre-tax earnings improved from a US-only pre-tax income of $14.1 million in 2018 to US-only pre-tax income of $38.4 million in 2019, a 172% improvement from prior year. The primary driver for the increase in operating income is related to our continued margin expansion provided by direct marketing and operating expense while improving credit quality in the loan portfolio during the past year.
|
•
|
The Company is in a three-year cumulative pre-tax income position in 2019. Additionally, the Company expects full utilization of its NOL carryforward in 2019 as well as approximately 20% of its research and development credits.
|
•
|
Due to the short-term nature of the loan portfolio and the other material items that comprise the US deferred tax assets, net, the Company estimates that the majority of these deferred tax items will reverse within one to three years.
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Beginning balance
|
|
$
|
2,334
|
|
|
$
|
925
|
|
Accruals
|
|
2,294
|
|
|
1,124
|
|
||
Payments
|
|
(2,017
|
)
|
|
(922
|
)
|
||
Effects of changes in foreign currency rates
|
|
66
|
|
|
2
|
|
||
Ending balance
|
|
$
|
2,677
|
|
|
$
|
1,129
|
|
Elevate Credit, Inc. and Subsidiaries
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended March 31,
|
||
(Dollars in thousands)
|
|
2020
|
||
Beginning balance
|
|
$
|
—
|
|
Expected loss
|
|
4,263
|
|
|
Net contingent loss related to a legal matter
|
|
$
|
4,263
|
|
Elevate Credit, Inc. and Subsidiaries
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Revenues
|
|
|
|
|
||||
United States
|
|
$
|
162,467
|
|
|
$
|
160,066
|
|
United Kingdom
|
|
14,988
|
|
|
29,438
|
|
||
Total
|
|
$
|
177,455
|
|
|
$
|
189,504
|
|
|
|
|
|
|
||||
|
|
March 31,
2020 |
|
December 31,
2019 |
||||
Long-lived assets
|
|
|
|
|
||||
United States
|
|
$
|
54,091
|
|
|
$
|
54,313
|
|
United Kingdom
|
|
13,707
|
|
|
23,296
|
|
||
Total
|
|
$
|
67,798
|
|
|
$
|
77,609
|
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Fees and travel expenses
|
|
$
|
183
|
|
|
$
|
131
|
|
Stock compensation
|
|
1,006
|
|
|
366
|
|
||
Consulting
|
|
114
|
|
|
75
|
|
||
Total board related expenses
|
|
$
|
1,303
|
|
|
$
|
572
|
|
Elevate Credit, Inc. and Subsidiaries
|
•
|
Revenue growth. Key metrics related to revenue growth that we monitor by product include the ending and average combined loan balances outstanding, the effective APR of our product loan portfolios, the total dollar value of loans originated, the number of new customer loans made, the ending number of customer loans outstanding and the related customer acquisition costs (“CAC”) associated with each new customer loan made. We include CAC as a key metric when analyzing revenue growth (rather than as a key metric within margin expansion).
|
•
|
Stable credit quality. Since the time they were managing our legacy US products, our management team has maintained stable credit quality across the loan portfolio they were managing. Additionally, in the periods covered in this Management's Discussion and Analysis of Financial Condition and Results of Operations, we have improved our credit quality. The credit quality metrics we monitor include net charge-offs as a percentage of revenues, the combined loan loss reserve as a percentage of outstanding combined loans, total provision for loan losses as a percentage of revenues and the percentage of past due combined loans receivable – principal.
|
•
|
Margin expansion. We expect that our operating margins will continue to expand over the long term as we lower our direct marketing costs and efficiently manage our operating expenses while continuing to improve our credit quality. Over the next several years, as we continue to scale our loan portfolio, we anticipate that our direct marketing costs primarily associated with new customer acquisitions will decline to approximately 10% of revenues and our operating expenses will decline to approximately 20% of revenues. We aim to manage our business to achieve a long-term operating margin of 20%, and do not expect our operating margin to increase beyond that level, as we intend to pass on any improvements over our targeted margins to our customers in the form of lower APRs. We believe this is a critical component of our responsible lending platform and over time will also help us continue to attract new customers and retain existing customers.
|
|
|
As of and for the three months ended March 31,
|
||||||
Revenue metrics (dollars in thousands, except as noted)
|
|
2020
|
|
2019
|
||||
Revenues
|
|
$
|
177,455
|
|
|
$
|
189,504
|
|
Period-over-period change in revenue
|
|
(6
|
)%
|
|
(2
|
)%
|
||
Ending combined loans receivable – principal(1)
|
|
577,697
|
|
|
575,131
|
|
||
Average combined loans receivable – principal(1)(2)
|
|
613,585
|
|
|
609,192
|
|
||
Total combined loans originated – principal
|
|
250,227
|
|
|
298,264
|
|
||
Average customer loan balance (in dollars)(3)
|
|
1,707
|
|
|
1,577
|
|
||
Number of new customer loans
|
|
46,590
|
|
|
50,476
|
|
||
Ending number of combined loans outstanding
|
|
338,415
|
|
|
364,679
|
|
||
Customer acquisition costs (in dollars)
|
|
259
|
|
|
221
|
|
||
Effective APR of combined loan portfolio
|
|
116
|
%
|
|
126
|
%
|
(1)
|
Combined loans receivable is defined as loans owned by the Company and consolidated VIEs plus loans originated and owned by third-party lenders pursuant to our CSO programs. See “—Non-GAAP Financial Measures” for more information and for a reconciliation of Combined loans receivable to Loans receivable, net, the most directly comparable financial measure calculated in accordance with US GAAP.
|
(2)
|
Average combined loans receivable – principal is calculated using an average of daily Combined loans receivable – principal balances.
|
(3)
|
Average customer loan balance is an average of all four products and is calculated for each product by dividing the ending Combined loans receivable – principal by the number of loans outstanding at period end.
|
|
|
Three Months Ended March 31, 2020
|
||||||||||||||||||
|
|
Rise (US)
|
|
Elastic (US)(1)
|
|
Total Domestic
|
|
Sunny (UK)
|
|
Total
|
||||||||||
Beginning number of combined loans outstanding
|
|
152,435
|
|
|
149,524
|
|
|
301,959
|
|
|
72,525
|
|
|
374,484
|
|
|||||
New customer loans originated
|
|
24,413
|
|
|
11,337
|
|
|
35,750
|
|
|
10,840
|
|
|
46,590
|
|
|||||
Former customer loans originated
|
|
16,556
|
|
|
131
|
|
|
16,687
|
|
|
—
|
|
|
16,687
|
|
|||||
Attrition
|
|
(50,771
|
)
|
|
(22,139
|
)
|
|
(72,910
|
)
|
|
(26,436
|
)
|
|
(99,346
|
)
|
|||||
Ending number of combined loans outstanding
|
|
142,633
|
|
|
138,853
|
|
|
281,486
|
|
|
56,929
|
|
|
338,415
|
|
|||||
Customer acquisition cost
|
|
$
|
309
|
|
|
$
|
303
|
|
|
$
|
307
|
|
|
$
|
102
|
|
|
$
|
259
|
|
Average customer loan balance
|
|
$
|
2,269
|
|
|
$
|
1,656
|
|
|
$
|
1,966
|
|
|
$
|
425
|
|
|
$
|
1,707
|
|
|
|
Three Months Ended March 31, 2019
|
||||||||||||||||||
|
|
Rise (US)
|
|
Elastic (US)(1)
|
|
Total Domestic
|
|
Sunny (UK)
|
|
Total
|
||||||||||
Beginning number of combined loans outstanding
|
|
142,758
|
|
|
166,397
|
|
|
309,155
|
|
|
89,449
|
|
|
398,604
|
|
|||||
New customer loans originated
|
|
17,365
|
|
|
4,838
|
|
|
22,203
|
|
|
28,273
|
|
|
50,476
|
|
|||||
Former customer loans originated
|
|
17,791
|
|
|
9
|
|
|
17,800
|
|
|
—
|
|
|
17,800
|
|
|||||
Attrition
|
|
(52,893
|
)
|
|
(25,484
|
)
|
|
(78,377
|
)
|
|
(23,824
|
)
|
|
(102,201
|
)
|
|||||
Ending number of combined loans outstanding
|
|
125,021
|
|
|
145,760
|
|
|
270,781
|
|
|
93,898
|
|
|
364,679
|
|
|||||
Customer acquisition cost
|
|
$
|
333
|
|
|
$
|
294
|
|
|
$
|
324
|
|
|
$
|
140
|
|
|
$
|
221
|
|
Average customer loan balance
|
|
$
|
2,241
|
|
|
$
|
1,685
|
|
|
$
|
1,941
|
|
|
$
|
527
|
|
|
$
|
1,577
|
|
|
|
As of and for the three months ended March 31,
|
||||||
Credit quality metrics (dollars in thousands)
|
|
2020
|
|
2019
|
||||
Net charge-offs(1)
|
|
$
|
88,064
|
|
|
$
|
103,985
|
|
Additional provision for loan losses(1)
|
|
(5,311
|
)
|
|
(16,554
|
)
|
||
Provision for loan losses
|
|
$
|
82,753
|
|
|
$
|
87,431
|
|
Past due combined loans receivable – principal as a percentage of combined loans receivable – principal(2)
|
|
10
|
%
|
|
10
|
%
|
||
Net charge-offs as a percentage of revenues(1)
|
|
50
|
%
|
|
55
|
%
|
||
Total provision for loan losses as a percentage of revenues
|
|
47
|
%
|
|
46
|
%
|
||
Combined loan loss reserve(3)
|
|
$
|
83,387
|
|
|
$
|
79,699
|
|
Combined loan loss reserve as a percentage of combined loans receivable(3)(4)
|
|
14
|
%
|
|
13
|
%
|
(1)
|
Net charge-offs and additional provision for loan losses are not financial measures prepared in accordance with US GAAP. Net charge-offs include the amount of principal and accrued interest on loans that are more than 60 days past due, or sooner if we receive notice that the loan will not be collected, such as a bankruptcy notice or identified fraud, offset by any recoveries. Additional provision for loan losses is the amount of provision for loan losses needed for a particular period to adjust the combined loan loss reserve to the appropriate level in accordance with our underlying loan loss reserve methodology. See “—Non-GAAP Financial Measures” for more information and for a reconciliation to Provision for loan losses, the most directly comparable financial measure calculated in accordance with US GAAP.
|
(2)
|
Combined loans receivable is defined as loans owned by the Company and consolidated VIEs plus loans originated and owned by third-party lenders pursuant to our CSO programs. See “—Non-GAAP Financial Measures” for more information and for a reconciliation of Combined loans receivable to Loans receivable, net, the most directly comparable financial measure calculated in accordance with US GAAP.
|
(3)
|
Combined loan loss reserve is defined as the loan loss reserve for loans originated and owned by the Company plus the loan loss reserve for loans owned by third-party lenders and guaranteed by the Company. See “—Non-GAAP Financial Measures” for more information and for a reconciliation of Combined loan loss reserve to Allowance for loan losses, the most directly comparable financial measure calculated in accordance with US GAAP.
|
(4)
|
Combined loan loss reserve as a percentage of combined loans receivable is determined using period-end balances.
|
Net principal charge-offs as a percentage of average combined loans receivable - principal (1) (2) (3)
|
|
First
Quarter
|
|
Second
Quarter
|
|
Third
Quarter
|
|
Fourth
Quarter
|
2020
|
|
11%
|
|
N/A
|
|
N/A
|
|
N/A
|
2019
|
|
13%
|
|
11%
|
|
11%
|
|
13%
|
2018
|
|
13%
|
|
12%
|
|
13%
|
|
14%
|
(1)
|
Net principal charge-offs is comprised of gross principal charge-offs less recoveries.
|
(2)
|
Average combined loans receivable - principal is calculated using an average of daily Combined loans receivable - principal balances during each quarter.
|
(3)
|
Combined loans receivable is defined as loans owned by the Company and consolidated VIEs plus loans originated and owned by third-party lenders pursuant to our CSO programs. See “—Non-GAAP Financial Measures” for more information and for a reconciliation of Combined loans receivable to Loans receivable, net, the most directly comparable financial measure calculated in accordance with US GAAP.
|
Example (dollars in thousands)
|
|
|
|
|
|||
Beginning combined loan loss reserve
|
|
|
|
$
|
25,000
|
|
|
Less: Net charge-offs
|
|
|
|
(10,000
|
)
|
||
Provision for loan losses:
|
|
|
|
|
|||
Provision for net charge-offs
|
|
10,000
|
|
|
|
||
Additional provision for loan losses
|
|
5,000
|
|
|
|
||
Total provision for loan losses
|
|
|
|
15,000
|
|
||
Ending combined loan loss reserve balance
|
|
|
|
$
|
30,000
|
|
|
|
Three Months Ended
March 31, |
||||||
Margin metrics (dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
Revenues
|
|
$
|
177,455
|
|
|
$
|
189,504
|
|
Net charge-offs(1)
|
|
(88,064
|
)
|
|
(103,985
|
)
|
||
Additional provision for loan losses(1)
|
|
5,311
|
|
|
16,554
|
|
||
Direct marketing costs
|
|
(12,071
|
)
|
|
(11,154
|
)
|
||
Other cost of sales
|
|
(8,330
|
)
|
|
(5,060
|
)
|
||
Gross profit
|
|
74,301
|
|
|
85,859
|
|
||
Operating expenses
|
|
(48,619
|
)
|
|
(47,880
|
)
|
||
Operating income
|
|
$
|
25,682
|
|
|
$
|
37,979
|
|
As a percentage of revenues:
|
|
|
|
|
||||
Net charge-offs
|
|
50
|
%
|
|
55
|
%
|
||
Additional provision for loan losses
|
|
(3
|
)
|
|
(9
|
)
|
||
Direct marketing costs
|
|
7
|
|
|
6
|
|
||
Other cost of sales
|
|
5
|
|
|
3
|
|
||
Gross margin
|
|
42
|
|
|
45
|
|
||
Operating expenses
|
|
27
|
|
|
25
|
|
||
Operating margin
|
|
14
|
%
|
|
20
|
%
|
(1)
|
Non-GAAP measure. See “—Non-GAAP Financial Measures—Net charge-offs and additional provision for loan losses.”
|
•
|
Impairment on goodwill
|
•
|
Contingent loss related to a legal matter
|
•
|
Cumulative tax effect of adjustments
|
|
|
Three Months Ended
March 31, |
||||||
(Dollars in thousands except per share amounts)
|
|
2020
|
|
2019
|
||||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
Impact of impairment loss (1)
|
|
9,251
|
|
|
—
|
|
||
Impact of contingent legal loss
|
|
4,263
|
|
|
—
|
|
||
Cumulative tax effect of adjustments
|
|
(1,006
|
)
|
|
—
|
|
||
Adjusted net income
|
|
$
|
7,597
|
|
|
$
|
13,358
|
|
|
|
|
|
|
||||
Diluted (loss) earnings per share
|
|
$
|
(0.11
|
)
|
|
$
|
0.30
|
|
Impact of impairment loss (1)
|
|
0.21
|
|
|
—
|
|
||
Impact of contingent legal loss
|
|
0.09
|
|
|
—
|
|
||
Cumulative tax effect of adjustments
|
|
(0.02
|
)
|
|
—
|
|
||
Adjusted diluted earnings per share
|
|
$
|
0.17
|
|
|
$
|
0.30
|
|
|
|
|
|
|
||||
Diluted weighted average shares outstanding
|
|
43,161,716
|
|
|
43,875,410
|
|
||
Effect of potentially dilutive shares outstanding (2)
|
|
470,021
|
|
|
—
|
|
||
Adjusted diluted weighted average shares outstanding
|
|
43,631,737
|
|
|
43,875,410
|
|
•
|
Net interest expense, primarily associated with notes payable under the VPC Facility, EF SPV Facility and ESPV Facility used to fund the loan portfolios;
|
•
|
Share-based compensation;
|
•
|
Foreign currency gains and losses associated with our UK operations;
|
•
|
Depreciation and amortization expense on fixed assets and intangible assets;
|
•
|
Impairment loss on goodwill;
|
•
|
Gains and losses from fair value adjustments, dispositions or contingent losses related to legal matters included in non-operating losses; and
|
•
|
Income taxes.
|
•
|
Although depreciation and amortization are non-cash charges, the assets being depreciated and amortized may have to be replaced in the future, and Adjusted EBITDA does not reflect expected cash capital expenditure requirements for such replacements or for new capital assets;
|
•
|
Adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; and
|
•
|
Adjusted EBITDA does not reflect interest associated with notes payable used for funding the loan portfolios, for other corporate purposes or tax payments that may represent a reduction in cash available to us.
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
Adjustments:
|
|
|
|
|
||||
Net interest expense
|
|
14,195
|
|
|
19,219
|
|
||
Share-based compensation
|
|
2,777
|
|
|
2,435
|
|
||
Foreign currency transaction loss (gain)
|
|
812
|
|
|
(613
|
)
|
||
Depreciation and amortization
|
|
4,797
|
|
|
4,266
|
|
||
Impairment loss
|
|
9,251
|
|
|
—
|
|
||
Non-operating loss
|
|
4,263
|
|
|
—
|
|
||
Income tax expense
|
|
2,072
|
|
|
6,015
|
|
||
Adjusted EBITDA
|
|
$
|
33,256
|
|
|
$
|
44,680
|
|
|
|
|
|
|
||||
Adjusted EBITDA margin
|
|
19
|
%
|
|
24
|
%
|
•
|
Net charge-offs – combined principal loans; and
|
•
|
Capital expenditures.
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
||||||
Net cash provided by operating activities(1)
|
|
$
|
76,699
|
|
|
$
|
97,762
|
|
Adjustments:
|
|
|
|
|
||||
Net charge-offs – combined principal loans
|
|
(67,352
|
)
|
|
(81,166
|
)
|
||
Capital expenditures
|
|
(5,565
|
)
|
|
(7,105
|
)
|
||
FCF
|
|
$
|
3,782
|
|
|
$
|
9,491
|
|
(1)
|
Net cash provided by operating activities includes net charge-offs – combined finance charges.
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
Net charge-offs
|
|
$
|
88,064
|
|
|
$
|
103,985
|
|
Additional provision for loan losses
|
|
(5,311
|
)
|
|
(16,554
|
)
|
||
Provision for loan losses
|
|
$
|
82,753
|
|
|
$
|
87,431
|
|
•
|
Rise CSO loans are originated and owned by a third-party lender and
|
•
|
Rise CSO loans are funded by a third-party lender and are not part of the VPC Facility.
|
•
|
Loans receivable, net, Company owned (which reconciles to our Condensed Consolidated Balance Sheets included elsewhere in this Quarterly Report on Form 10-Q);
|
•
|
Loans receivable, net, guaranteed by the Company (as disclosed in Note 3 of our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q);
|
•
|
Combined loans receivable (which we use as a non-GAAP measure); and
|
•
|
Combined loan loss reserve (which we use as a non-GAAP measure).
|
|
|
2019
|
|
2020
|
||||||||||||||||
(Dollars in thousands)
|
|
March 31
|
|
June 30
|
|
September 30
|
|
December 31
|
|
March 31
|
||||||||||
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Company Owned Loans:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans receivable – principal, current, company owned
|
|
$
|
491,208
|
|
|
$
|
523,785
|
|
|
$
|
543,565
|
|
|
$
|
559,169
|
|
|
$
|
506,408
|
|
Loans receivable – principal, past due, company owned
|
|
55,286
|
|
|
55,711
|
|
|
65,824
|
|
|
63,413
|
|
|
58,119
|
|
|||||
Loans receivable – principal, total, company owned
|
|
546,494
|
|
|
579,496
|
|
|
609,389
|
|
|
622,582
|
|
|
564,527
|
|
|||||
Loans receivable – finance charges, company owned
|
|
32,491
|
|
|
31,805
|
|
|
35,702
|
|
|
38,091
|
|
|
33,959
|
|
|||||
Loans receivable – company owned
|
|
578,985
|
|
|
611,301
|
|
|
645,091
|
|
|
660,673
|
|
|
598,486
|
|
|||||
Allowance for loan losses on loans receivable, company owned
|
|
(76,457
|
)
|
|
(75,896
|
)
|
|
(89,667
|
)
|
|
(86,996
|
)
|
|
(81,816
|
)
|
|||||
Loans receivable, net, company owned
|
|
$
|
502,528
|
|
|
$
|
535,405
|
|
|
$
|
555,424
|
|
|
$
|
573,677
|
|
|
$
|
516,670
|
|
Third Party Loans Guaranteed by the Company:
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Loans receivable – principal, current, guaranteed by company
|
|
$
|
27,941
|
|
|
$
|
21,099
|
|
|
$
|
18,633
|
|
|
$
|
17,474
|
|
|
$
|
12,606
|
|
Loans receivable – principal, past due, guaranteed by company
|
|
696
|
|
|
596
|
|
|
697
|
|
|
723
|
|
|
564
|
|
|||||
Loans receivable – principal, total, guaranteed by company(1)
|
|
28,637
|
|
|
21,695
|
|
|
19,330
|
|
|
18,197
|
|
|
13,170
|
|
|||||
Loans receivable – finance charges, guaranteed by company(2)
|
|
2,164
|
|
|
1,676
|
|
|
1,553
|
|
|
1,395
|
|
|
1,150
|
|
|||||
Loans receivable – guaranteed by company
|
|
30,801
|
|
|
23,371
|
|
|
20,883
|
|
|
19,592
|
|
|
14,320
|
|
|||||
Liability for losses on loans receivable, guaranteed by company
|
|
(3,242
|
)
|
|
(1,983
|
)
|
|
(1,972
|
)
|
|
(2,079
|
)
|
|
(1,571
|
)
|
|||||
Loans receivable, net, guaranteed by company(2)
|
|
$
|
27,559
|
|
|
$
|
21,388
|
|
|
$
|
18,911
|
|
|
$
|
17,513
|
|
|
$
|
12,749
|
|
Combined Loans Receivable(3):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Combined loans receivable – principal, current
|
|
$
|
519,149
|
|
|
$
|
544,884
|
|
|
$
|
562,198
|
|
|
$
|
576,643
|
|
|
$
|
519,014
|
|
Combined loans receivable – principal, past due
|
|
55,982
|
|
|
56,307
|
|
|
66,521
|
|
|
64,136
|
|
|
58,683
|
|
|||||
Combined loans receivable – principal
|
|
575,131
|
|
|
601,191
|
|
|
628,719
|
|
|
640,779
|
|
|
577,697
|
|
|||||
Combined loans receivable – finance charges
|
|
34,655
|
|
|
33,481
|
|
|
37,255
|
|
|
39,486
|
|
|
35,109
|
|
|||||
Combined loans receivable
|
|
$
|
609,786
|
|
|
$
|
634,672
|
|
|
$
|
665,974
|
|
|
$
|
680,265
|
|
|
$
|
612,806
|
|
Combined Loan Loss Reserve(3):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Allowance for loan losses on loans receivable, company owned
|
|
$
|
(76,457
|
)
|
|
$
|
(75,896
|
)
|
|
$
|
(89,667
|
)
|
|
$
|
(86,996
|
)
|
|
$
|
(81,816
|
)
|
Liability for losses on loans receivable, guaranteed by company
|
|
(3,242
|
)
|
|
(1,983
|
)
|
|
(1,972
|
)
|
|
(2,079
|
)
|
|
(1,571
|
)
|
|||||
Combined loan loss reserve
|
|
$
|
(79,699
|
)
|
|
$
|
(77,879
|
)
|
|
$
|
(91,639
|
)
|
|
$
|
(89,075
|
)
|
|
$
|
(83,387
|
)
|
Combined loans receivable – principal, past due(3)
|
|
$
|
55,982
|
|
|
$
|
56,307
|
|
|
$
|
66,521
|
|
|
$
|
64,136
|
|
|
$
|
58,683
|
|
Combined loans receivable – principal(3)
|
|
575,131
|
|
|
$
|
601,191
|
|
|
$
|
628,719
|
|
|
$
|
640,779
|
|
|
$
|
577,697
|
|
|
Percentage past due(1)
|
|
10
|
%
|
|
9
|
%
|
|
11
|
%
|
|
10
|
%
|
|
10
|
%
|
|||||
Combined loan loss reserve as a percentage of combined loans receivable(3)(4)
|
|
13
|
%
|
|
12
|
%
|
|
14
|
%
|
|
13
|
%
|
|
14
|
%
|
|||||
Allowance for loan losses as a percentage of loans receivable – company owned
|
|
13
|
%
|
|
12
|
%
|
|
14
|
%
|
|
13
|
%
|
|
14
|
%
|
(1)
|
Represents loans originated by third-party lenders through the CSO programs, which are not included in our condensed consolidated financial statements.
|
(2)
|
Represents finance charges earned by third-party lenders through the CSO programs, which are not included in our condensed consolidated financial statements.
|
(3)
|
Non-GAAP measure.
|
(4)
|
Combined loan loss reserve as a percentage of combined loans receivable is determined using period-end balances.
|
|
|
Three Months Ended
March 31, |
||||||
Condensed consolidated statements of operations data (dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
||||||
Revenues
|
|
$
|
177,455
|
|
|
$
|
189,504
|
|
Cost of sales:
|
|
|
|
|
||||
Provision for loan losses
|
|
82,753
|
|
|
87,431
|
|
||
Direct marketing costs
|
|
12,071
|
|
|
11,154
|
|
||
Other cost of sales
|
|
8,330
|
|
|
5,060
|
|
||
Total cost of sales
|
|
103,154
|
|
|
103,645
|
|
||
Gross profit
|
|
74,301
|
|
|
85,859
|
|
||
Operating expenses:
|
|
|
|
|
||||
Compensation and benefits
|
|
26,191
|
|
|
25,710
|
|
||
Professional services
|
|
9,207
|
|
|
9,699
|
|
||
Selling and marketing
|
|
1,424
|
|
|
1,846
|
|
||
Occupancy and equipment
|
|
5,749
|
|
|
5,052
|
|
||
Depreciation and amortization
|
|
4,797
|
|
|
4,266
|
|
||
Other
|
|
1,251
|
|
|
1,307
|
|
||
Total operating expenses
|
|
48,619
|
|
|
47,880
|
|
||
Operating income
|
|
25,682
|
|
|
37,979
|
|
||
Other expense:
|
|
|
|
|
||||
Net interest expense
|
|
(14,195
|
)
|
|
(19,219
|
)
|
||
Foreign currency transaction (loss) gain
|
|
(812
|
)
|
|
613
|
|
||
Impairment loss
|
|
(9,251
|
)
|
|
—
|
|
||
Non-operating loss
|
|
(4,263
|
)
|
|
—
|
|
||
Total other expense
|
|
(28,521
|
)
|
|
(18,606
|
)
|
||
Income (loss) before taxes
|
|
(2,839
|
)
|
|
19,373
|
|
||
Income tax expense
|
|
2,072
|
|
|
6,015
|
|
||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
$
|
13,358
|
|
|
|
Three Months Ended
March 31, |
||||
As a percentage of revenues
|
|
2020
|
|
2019
|
||
|
|
|
||||
Cost of sales:
|
|
|
|
|
||
Provision for loan losses
|
|
47
|
%
|
|
46
|
%
|
Direct marketing costs
|
|
7
|
|
|
6
|
|
Other cost of sales
|
|
5
|
|
|
3
|
|
Total cost of sales
|
|
58
|
|
|
55
|
|
Gross profit
|
|
42
|
|
|
45
|
|
Operating expenses:
|
|
|
|
|
||
Compensation and benefits
|
|
15
|
|
|
14
|
|
Professional services
|
|
5
|
|
|
5
|
|
Selling and marketing
|
|
1
|
|
|
1
|
|
Occupancy and equipment
|
|
3
|
|
|
3
|
|
Depreciation and amortization
|
|
3
|
|
|
2
|
|
Other
|
|
1
|
|
|
1
|
|
Total operating expenses
|
|
27
|
|
|
25
|
|
Operating income
|
|
14
|
|
|
20
|
|
Other expense:
|
|
|
|
|
||
Net interest expense
|
|
(8
|
)
|
|
(10
|
)
|
Foreign currency transaction (loss) gain
|
|
—
|
|
|
—
|
|
Impairment loss
|
|
(5
|
)
|
|
—
|
|
Non-operating loss
|
|
(2
|
)
|
|
—
|
|
Total other expense
|
|
(16
|
)
|
|
(10
|
)
|
Income (loss) before taxes
|
|
(2
|
)
|
|
10
|
|
Income tax expense
|
|
2
|
|
|
3
|
|
Net (loss) income
|
|
(3
|
)%
|
|
7
|
%
|
|
|
Three Months Ended March 31,
|
|
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
Period-to-period change
|
|||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
|
|||||||||||||||||||
Finance charges
|
|
$
|
177,049
|
|
|
100
|
%
|
|
$
|
188,989
|
|
|
100
|
%
|
|
$
|
(11,940
|
)
|
|
(6
|
)%
|
Other
|
|
406
|
|
|
—
|
|
|
515
|
|
|
—
|
|
|
(109
|
)
|
|
(21
|
)
|
|||
Revenues
|
|
$
|
177,455
|
|
|
100
|
%
|
|
$
|
189,504
|
|
|
100
|
%
|
|
$
|
(12,049
|
)
|
|
(6
|
)%
|
|
|
Three Months Ended March 31, 2020
|
||||||||||||||||||
(Dollars in thousands)
|
|
Rise (US)(1)
|
|
Elastic (US)(2)
|
|
Total
Domestic |
|
Sunny (UK)
|
|
Total
|
||||||||||
|
|
|
||||||||||||||||||
Average combined loans receivable – principal(3)
|
|
$
|
339,264
|
|
|
$
|
243,906
|
|
|
$
|
583,170
|
|
|
$
|
30,415
|
|
|
$
|
613,585
|
|
Effective APR
|
|
123
|
%
|
|
97
|
%
|
|
112
|
%
|
|
198
|
%
|
|
116
|
%
|
|||||
Finance charges
|
|
$
|
103,505
|
|
|
$
|
58,573
|
|
|
$
|
162,078
|
|
|
$
|
14,971
|
|
|
$
|
177,049
|
|
Other
|
|
99
|
|
|
289
|
|
|
388
|
|
|
18
|
|
|
406
|
|
|||||
Total revenue
|
|
$
|
103,604
|
|
|
$
|
58,862
|
|
|
$
|
162,466
|
|
|
$
|
14,989
|
|
|
$
|
177,455
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
|
Three Months Ended March 31, 2019
|
||||||||||||||||||
(Dollars in thousands)
|
|
Rise (US)(1)
|
|
Elastic (US)(2)
|
|
Total
Domestic |
|
Sunny (UK)
|
|
Total
|
||||||||||
|
|
|
||||||||||||||||||
Average combined loans receivable – principal(3)
|
|
$
|
290,450
|
|
|
$
|
266,396
|
|
|
$
|
556,846
|
|
|
$
|
52,346
|
|
|
$
|
609,192
|
|
Effective APR
|
|
132
|
%
|
|
99
|
%
|
|
116
|
%
|
|
228
|
%
|
|
126
|
%
|
|||||
Finance charges
|
|
$
|
94,885
|
|
|
$
|
64,733
|
|
|
$
|
159,618
|
|
|
$
|
29,371
|
|
|
$
|
188,989
|
|
Other
|
|
351
|
|
|
96
|
|
|
447
|
|
|
68
|
|
|
515
|
|
|||||
Total revenue
|
|
$
|
95,236
|
|
|
$
|
64,829
|
|
|
$
|
160,065
|
|
|
$
|
29,439
|
|
|
$
|
189,504
|
|
|
|
Three Months Ended March 31,
|
|
Period-to-period
change
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
||||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
|
|||||||||||||||||||
Cost of sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Provision for loan losses
|
|
$
|
82,753
|
|
|
47
|
%
|
|
$
|
87,431
|
|
|
46
|
%
|
|
$
|
(4,678
|
)
|
|
(5
|
)%
|
Direct marketing costs
|
|
12,071
|
|
|
7
|
|
|
11,154
|
|
|
6
|
|
|
917
|
|
|
8
|
|
|||
Other cost of sales
|
|
8,330
|
|
|
5
|
|
|
5,060
|
|
|
3
|
|
|
3,270
|
|
|
65
|
|
|||
Total cost of sales
|
|
$
|
103,154
|
|
|
58
|
%
|
|
$
|
103,645
|
|
|
55
|
%
|
|
$
|
(491
|
)
|
|
—
|
%
|
|
|
Three Months Ended March 31, 2020
|
||||||||||||||||||
(Dollars in thousands)
|
|
Rise (US)
|
|
Elastic (US)(1)
|
|
Total
Domestic
|
|
Sunny (UK)
|
|
Total
|
||||||||||
|
|
|
||||||||||||||||||
Combined loan loss reserve(2):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning balance
|
|
$
|
52,099
|
|
|
$
|
29,893
|
|
|
$
|
81,992
|
|
|
$
|
7,083
|
|
|
$
|
89,075
|
|
Net charge-offs
|
|
(54,961
|
)
|
|
(27,846
|
)
|
|
(82,807
|
)
|
|
(5,257
|
)
|
|
(88,064
|
)
|
|||||
Provision for loan losses
|
|
54,569
|
|
|
24,006
|
|
|
78,575
|
|
|
4,178
|
|
|
82,753
|
|
|||||
Effect of foreign currency
|
|
—
|
|
|
—
|
|
|
—
|
|
|
(377
|
)
|
|
(377
|
)
|
|||||
Ending balance
|
|
$
|
51,707
|
|
|
$
|
26,053
|
|
|
$
|
77,760
|
|
|
$
|
5,627
|
|
|
$
|
83,387
|
|
Combined loans receivable(2)(3)
|
|
$
|
346,212
|
|
|
$
|
240,048
|
|
|
$
|
586,260
|
|
|
$
|
26,546
|
|
|
$
|
612,806
|
|
Combined loan loss reserve as a percentage of ending combined loans receivable
|
|
15
|
%
|
|
11
|
%
|
|
13
|
%
|
|
21
|
%
|
|
14
|
%
|
|||||
Net charge-offs as a percentage of revenues
|
|
53
|
%
|
|
47
|
%
|
|
51
|
%
|
|
35
|
%
|
|
50
|
%
|
|||||
Provision for loan losses as a percentage of revenues
|
|
53
|
%
|
|
41
|
%
|
|
48
|
%
|
|
28
|
%
|
|
47
|
%
|
|
|
Three Months Ended March 31, 2019
|
||||||||||||||||||
(Dollars in thousands)
|
|
Rise (US)
|
|
Elastic (US)(1)
|
|
Total
Domestic
|
|
Sunny (UK)
|
|
Total
|
||||||||||
|
|
|
||||||||||||||||||
Combined loan loss reserve(2):
|
|
|
|
|
|
|
|
|
|
|
||||||||||
Beginning balance
|
|
$
|
50,597
|
|
|
$
|
36,050
|
|
|
$
|
86,647
|
|
|
$
|
9,405
|
|
|
$
|
96,052
|
|
Net charge-offs
|
|
(57,040
|
)
|
|
(37,271
|
)
|
|
(94,311
|
)
|
|
(9,674
|
)
|
|
(103,985
|
)
|
|||||
Provision for loan losses
|
|
45,793
|
|
|
29,562
|
|
|
75,355
|
|
|
12,076
|
|
|
87,431
|
|
|||||
Effect of foreign currency
|
|
—
|
|
|
—
|
|
|
—
|
|
|
201
|
|
|
201
|
|
|||||
Ending balance
|
|
$
|
39,350
|
|
|
$
|
28,341
|
|
|
$
|
67,691
|
|
|
$
|
12,008
|
|
|
$
|
79,699
|
|
Combined loans receivable(2)(3)
|
|
$
|
298,759
|
|
|
$
|
256,618
|
|
|
$
|
555,377
|
|
|
$
|
54,409
|
|
|
$
|
609,786
|
|
Combined loan loss reserve as a percentage of ending combined loans receivable
|
|
13
|
%
|
|
11
|
%
|
|
12
|
%
|
|
22
|
%
|
|
13
|
%
|
|||||
Net charge-offs as a percentage of revenues
|
|
60
|
%
|
|
57
|
%
|
|
59
|
%
|
|
33
|
%
|
|
55
|
%
|
|||||
Provision for loan losses as a percentage of revenues
|
|
48
|
%
|
|
46
|
%
|
|
47
|
%
|
|
41
|
%
|
|
46
|
%
|
|
|
Three Months Ended March 31,
|
|
Period-to-period
change
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
||||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
|
|||||||||||||||||||
Operating expenses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||
Compensation and benefits
|
|
$
|
26,191
|
|
|
15
|
%
|
|
$
|
25,710
|
|
|
14
|
%
|
|
$
|
481
|
|
|
2
|
%
|
Professional services
|
|
9,207
|
|
|
5
|
|
|
9,699
|
|
|
5
|
|
|
(492
|
)
|
|
(5
|
)
|
|||
Selling and marketing
|
|
1,424
|
|
|
1
|
|
|
1,846
|
|
|
1
|
|
|
(422
|
)
|
|
(23
|
)
|
|||
Occupancy and equipment
|
|
5,749
|
|
|
3
|
|
|
5,052
|
|
|
3
|
|
|
697
|
|
|
14
|
|
|||
Depreciation and amortization
|
|
4,797
|
|
|
3
|
|
|
4,266
|
|
|
2
|
|
|
531
|
|
|
12
|
|
|||
Other
|
|
1,251
|
|
|
1
|
|
|
1,307
|
|
|
1
|
|
|
(56
|
)
|
|
(4
|
)
|
|||
Total operating expenses
|
|
$
|
48,619
|
|
|
27
|
%
|
|
$
|
47,880
|
|
|
25
|
%
|
|
$
|
739
|
|
|
2
|
%
|
|
|
Three Months Ended March 31,
|
|
Period-to-period
change
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
||||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
|
|||||||||||||||||||
Net interest expense
|
|
$
|
14,195
|
|
|
8
|
%
|
|
$
|
19,219
|
|
|
10
|
%
|
|
$
|
(5,024
|
)
|
|
(26
|
)%
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
|
|
||||
VPC Facility
|
|
|
|
|
||||
Average facility balance during the period
|
|
$
|
217,415
|
|
|
$
|
286,857
|
|
Net interest expense
|
|
5,750
|
|
|
8,691
|
|
||
Effective cost of funds
|
|
10.6
|
%
|
|
12.3
|
%
|
||
|
|
|
|
|
||||
EF SPV Facility
|
|
|
|
|
||||
Average facility balance during the period
|
|
$
|
107,429
|
|
|
45,833
|
|
|
Net interest expense
|
|
2,637
|
|
|
1,274
|
|
||
Effective cost of funds
|
|
9.9
|
%
|
|
11.3
|
%
|
||
|
|
|
|
|
||||
ESPV Facility
|
|
|
|
|
||||
Average facility balance during the period
|
|
$
|
224,929
|
|
|
$
|
238,400
|
|
Net interest expense
|
|
5,807
|
|
|
9,254
|
|
||
Effective cost of funds
|
|
10.4
|
%
|
|
15.7
|
%
|
|
|
Three Months Ended March 31,
|
|
Period-to-period
change
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
||||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
|
|||||||||||||||||||
Income tax expense
|
|
$
|
2,072
|
|
|
2
|
%
|
|
$
|
6,015
|
|
|
3
|
%
|
|
$
|
(3,943
|
)
|
|
(66
|
)%
|
|
|
Three Months Ended March 31,
|
|
Period-to-period
change
|
|||||||||||||||||
|
|
2020
|
|
2019
|
|
||||||||||||||||
(Dollars in thousands)
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage of
revenues
|
|
Amount
|
|
Percentage
|
|||||||||
|
|
|
|||||||||||||||||||
Net (loss) income
|
|
$
|
(4,911
|
)
|
|
(3
|
)%
|
|
$
|
13,358
|
|
|
7
|
%
|
|
$
|
(18,269
|
)
|
|
(137
|
)%
|
•
|
A maximum borrowing amount of $350 million used to fund the Rise loan portfolio (“US Term Note”). Prior to the February 1, 2019 amendment, the interest rate paid on this facility was a base rate (defined as the 3-month LIBOR, with a 1% floor) plus 11%. This resulted in a blended interest rate paid of 10.23% on debt outstanding under this facility as of December 31, 2019. Upon the February 1, 2019 amendment date, the interest rate on the debt outstanding as of the amendment date was fixed through the January 1, 2024 maturity date at 10.23% (base rate of 2.73% plus 7.5%). All future borrowings under this facility will bear an interest rate at a base rate (defined as the greater of 3-month LIBOR, the five-year LIBOR swap rate or 1% ) plus 7.5% at the borrowing date. The weighted average base rate on the outstanding balance at March 31, 2020 was 2.73% and the overall interest rate was 10.23%.
|
•
|
A maximum borrowing amount of $124 million used to fund the UK Sunny loan portfolio (“UK Term Note”). Prior to the February 1, 2019 amendment, the interest rate paid on this facility was a base rate (defined as the 3-month LIBOR) plus 14%. This resulted in a blended interest rate paid of 10.23% on debt outstanding under this facility as of December 31, 2019. Upon the February 1, 2019 amendment date, the interest rate on the debt outstanding as of the amendment date was fixed through the January 1, 2024 maturity date at 10.23% (base rate of 2.73% plus 7.5%). All future borrowings under this facility will bear an interest rate at a base rate (defined as the greater of 3-month LIBOR, the five-year LIBOR swap rate or 1%) plus 7.5% at the borrowing date. The weighted average base rate on the outstanding balance at March 31, 2020 was 2.73% and the overall interest rate was 10.23%.
|
•
|
A maximum borrowing amount of $18 million used to fund working capital, and prior to February 1, 2019, at a base rate (defined as the 3-month LIBOR, with a 1% floor) plus 13% (“4th Tranche Term Note”). Upon the February 1, 2019 amendment date, the interest rate was fixed through the February 1, 2021 maturity date at a base rate of 2.73% plus 13%. The interest rate at both March 31, 2020 and December 31, 2019 was 15.73%, respectively. There was no change in the interest rate spread on this facility upon the February 1, 2019 amendment.
|
•
|
A revolving feature which provides the option to pay down up to 20% of the outstanding balance, excluding the 4th Tranche Term Note, once per year during the first quarter. Amounts paid down may be drawn again at a later date prior to maturity.
|
(Dollars in thousands)
|
|
March 31,
2020 |
December 31,
2019 |
||||
US Term Note bearing interest at the base rate + 7.5%
|
|
$
|
154,500
|
|
$
|
182,000
|
|
UK Term Note bearing interest at the base rate + 7.5%
|
|
16,154
|
|
29,635
|
|
||
4th Tranche Term Note bearing interest at the base rate + 13%
|
|
18,050
|
|
18,050
|
|
||
EF SPV Term Note bearing interest at the base rate + 7.5%
|
|
108,500
|
|
102,000
|
|
||
ESPV Term Note bearing interest at the base rate + 7.5%
|
|
219,500
|
|
226,000
|
|
||
Total
|
|
$
|
516,704
|
|
$
|
557,685
|
|
•
|
US Term Note - Pay down of $27.5 million under the revolver component of the facility;
|
•
|
UK Term Note - Pay down of $12.9 million under the revolver component of the facility;
|
•
|
EF SPV Term note - Draw of $6.5 million; and
|
•
|
ESPV Term Note - Pay down of $6.5 million under the revolver component of the facility.
|
|
|
As of and for the three months ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
||||||
Cash and cash equivalents
|
|
$
|
101,429
|
|
|
$
|
97,153
|
|
Restricted cash
|
|
2,190
|
|
|
2,493
|
|
||
Loans receivable, net
|
|
516,670
|
|
|
502,528
|
|
||
Cash provided by (used in):
|
|
|
|
|
||||
Operating activities
|
|
76,699
|
|
|
97,762
|
|
||
Investing activities
|
|
(18,458
|
)
|
|
(23,737
|
)
|
||
Financing activities
|
|
(44,980
|
)
|
|
(35,525
|
)
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
||||||
Cash used in investing activities
|
|
|
|
|
||||
Net loans issued to consumers, less repayments
|
|
$
|
(11,493
|
)
|
|
$
|
(15,427
|
)
|
Participation premium paid
|
|
(1,400
|
)
|
|
(1,205
|
)
|
||
Purchases of property and equipment
|
|
(5,565
|
)
|
|
(7,105
|
)
|
||
|
|
$
|
(18,458
|
)
|
|
$
|
(23,737
|
)
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
||||||
Cash provided by (used in) financing activities
|
|
|
|
|
||||
Proceeds from issuance of Notes payable, net
|
|
$
|
6,500
|
|
|
$
|
9,843
|
|
Payments on Notes payable
|
|
(46,939
|
)
|
|
(43,000
|
)
|
||
Debt issuance costs paid
|
|
(51
|
)
|
|
(2,390
|
)
|
||
Purchases of treasury stock
|
|
(4,203
|
)
|
|
—
|
|
||
Proceeds from issuance of stock, net
|
|
27
|
|
|
26
|
|
||
Taxes paid related to net share settlement
|
|
(314
|
)
|
|
—
|
|
||
Other activities
|
|
—
|
|
|
(4
|
)
|
||
|
|
$
|
(44,980
|
)
|
|
$
|
(35,525
|
)
|
|
|
Three Months Ended March 31,
|
||||||
(Dollars in thousands)
|
|
2020
|
|
2019
|
||||
|
|
|
||||||
Net cash provided by operating activities
|
|
$
|
76,699
|
|
|
$
|
97,762
|
|
Adjustments:
|
|
|
|
|
||||
Net charge-offs – combined principal loans
|
|
(67,352
|
)
|
|
(81,166
|
)
|
||
Capital expenditures
|
|
(5,565
|
)
|
|
(7,105
|
)
|
||
FCF
|
|
$
|
3,782
|
|
|
$
|
9,491
|
|
•
|
Competition from other online and traditional lenders and credit card providers;
|
•
|
Regulatory limitations that impact the non-prime lending products we can offer and the markets we can serve;
|
•
|
An evolving regulatory and legislative landscape;
|
•
|
Access to important marketing channels such as:
|
◦
|
Direct mail and electronic offers;
|
◦
|
TV and mass media;
|
◦
|
Direct marketing, including search engine marketing; and
|
◦
|
Strategic partnerships with affiliates;
|
•
|
Changes in consumer behavior;
|
•
|
Access to adequate financing;
|
•
|
Increasingly sophisticated fraudulent borrowing and online theft;
|
•
|
Challenges with new products and new markets;
|
•
|
Dependence on our proprietary technology infrastructure and security systems;
|
•
|
Dependence on our personnel and certain third parties with whom we do business;
|
•
|
Risk to our business if our systems are hacked or otherwise compromised;
|
•
|
Evolving industry standards;
|
•
|
Recruiting and retention of qualified personnel necessary to operate our business and
|
•
|
Fluctuations in the credit markets and demand for credit.
|
•
|
personnel, including significant increases to the total compensation we pay our employees as we grow our employee headcount;
|
•
|
marketing, including expenses relating to increased direct marketing efforts;
|
•
|
product development, including the continued development of our proprietary scoring methodology;
|
•
|
funding costs to support loan growth;
|
•
|
office space, as we increase the space we need for our growing employee base; and
|
•
|
general administration, including legal, accounting and other compliance expenses related to being a public company.
|
•
|
become past due in the payment of an outstanding obligation;
|
•
|
defaulted on a pre-existing debt obligation;
|
•
|
taken on additional debt; or
|
•
|
sustained other adverse financial events.
|
•
|
decreasing our organic rankings or paid search results;
|
•
|
creating difficulty for our customers in using our web and mobile sites;
|
•
|
producing more successful organic rankings, paid search results or tactical execution efforts for our competitors than for us; and
|
•
|
resulting in higher costs for acquiring new or returning customers.
|
•
|
local regulations and ordinances that impose requirements or restrictions related to certain loan product offerings and collection practices;
|
•
|
state laws and regulations that impose requirements related to loan or credit service disclosures and terms, credit discrimination, credit reporting, debt servicing and collection;
|
•
|
the Truth in Lending Act and Regulation Z promulgated thereunder, and similar state laws, which require certain disclosures to borrowers regarding the terms and conditions of their loans and credit transactions and other substantive consumer protections with respect to credit cards, such as an assessment of a borrower's ability to repay obligations and penalty fee limitations;
|
•
|
Section 5 of the Federal Trade Commission Act, which prohibits unfair and deceptive acts or practices in or affecting commerce, Section 1031 of the Dodd-Frank Act, which prohibits unfair, deceptive or abusive acts or practices in connection with any consumer financial product or service, and similar state laws that prohibit unfair and deceptive acts or practices;
|
•
|
the Equal Credit Opportunity Act and Regulation B promulgated thereunder and state non-discrimination laws, which generally prohibit creditors from discriminating against credit applicants on the basis of race, color, sex, age, religion, national origin, marital status, the fact that all or part of the applicant’s income derives from any public assistance program or the fact that the applicant has in good faith exercised any right under the federal Consumer Credit Protection Act;
|
•
|
the Fair Credit Reporting Act (the “FCRA”) as amended by the Fair and Accurate Credit Transactions Act, and similar state laws, which promote the accuracy, fairness and privacy of information in the files of consumer reporting agencies;
|
•
|
the Fair Debt Collection Practices Act (the “FDCPA”) and similar state and local debt collection laws, which provide guidelines and limitations on the conduct of third-party debt collectors and creditors in connection with the collection of consumer debts;
|
•
|
the Gramm-Leach-Bliley Act and Regulation P promulgated thereunder and similar state privacy laws, which include limitations on financial institutions’ disclosure of nonpublic personal information about a consumer to nonaffiliated third parties, in certain circumstances require financial institutions to limit the use and further disclosure of nonpublic personal information by nonaffiliated third parties to whom they disclose such information and require financial institutions to disclose certain privacy policies and practices with respect to information sharing with affiliated and nonaffiliated entities as well as to safeguard personal customer information, and other privacy laws and regulations;
|
•
|
the Bankruptcy Code and similar state insolvency laws, which limit the extent to which creditors may seek to enforce debts against parties who have filed for bankruptcy protection;
|
•
|
the Servicemembers Civil Relief Act and similar state laws, which allow military members and certain dependents to suspend or postpone certain civil obligations, as well as limit applicable rates, so that the military member can devote his or her full attention to military duties;
|
•
|
the Military Lending Act and Department of Defense rules, which limit the interest rate and fees that may be charged to military members and their dependents, requires certain disclosures and prohibits certain mandatory clauses among other restrictions;
|
•
|
the Electronic Fund Transfer Act and Regulation E promulgated thereunder, which provide disclosure requirements, guidelines and restrictions on the electronic transfer of funds from consumers’ asset accounts;
|
•
|
the Electronic Signatures in Global and National Commerce Act and similar state laws, particularly the Uniform Electronic Transactions Act, which authorize the creation of legally binding and enforceable agreements utilizing electronic records and signatures and, with consumer consent, permits required disclosures to be provided electronically;
|
•
|
the Bank Secrecy Act, which relates to compliance with anti-money laundering, customer due diligence and record-keeping policies and procedures; and
|
•
|
the Telephone Consumer Protection Act (the "TCPA") and the regulations of the Federal Communications Commission (the "FCC"), which regulations include limitations on telemarketing calls, auto-dialed calls, prerecorded calls, text messages and unsolicited faxes.
|
•
|
announcements of new products, services or technologies, relationships with strategic partners or acquisitions or changes in the timing of such anticipated events; of the termination of, or material changes to, material agreements; or of other events by us or our competitors;
|
•
|
changes in economic conditions;
|
•
|
changes in prevailing interest rates;
|
•
|
price and volume fluctuations in the overall stock market from time to time;
|
•
|
significant volatility in the market price and trading volume of technology companies in general and of companies in the financial services industry;
|
•
|
fluctuations in the trading volume of our shares or the size of our public float;
|
•
|
actual or anticipated changes in our operating results or fluctuations in our operating results;
|
•
|
quarterly fluctuations in demand for our loans;
|
•
|
whether our operating results meet the expectations of securities analysts or investors;
|
•
|
actual or anticipated changes in the expectations of investors or securities analysts;
|
•
|
regulatory developments in the US, foreign countries or both and our ability to comply with applicable regulations;
|
•
|
material litigation, including class action lawsuits;
|
•
|
major catastrophic events;
|
•
|
sales of large blocks of our stock;
|
•
|
entry into, modification of or termination of a material agreement; or
|
•
|
departures of key personnel or directors.
|
•
|
establish a classified Board of Directors so that not all members of our Board of Directors are elected at one time;
|
•
|
permit only our Board of Directors to establish the number of directors and fill vacancies on the Board;
|
•
|
provide that directors may only be removed “for cause” and only with the approval of two-thirds of our stockholders;
|
•
|
require two-thirds approval to amend some provisions in our restated certificate of incorporation and restated bylaws;
|
•
|
authorize the issuance of “blank check” preferred stock that our Board of Directors could use to implement a stockholder rights plan, or a “poison pill;”
|
•
|
eliminate the ability of our stockholders to call special meetings of stockholders;
|
•
|
prohibit stockholder action by written consent, which will require that all stockholder actions must be taken at a stockholder meeting;
|
•
|
do not provide for cumulative voting; and
|
•
|
establish advance notice requirements for nominations for election to our Board of Directors or for proposing matters that can be acted upon by stockholders at annual stockholder meetings.
|
Period
|
|
Total number of shares purchased
|
|
Average price paid per share (1)
|
|
Total number of shares purchased as part of the publicly announced program
|
|
Approximate dollar value of shares that may yet be purchased under the program (1)
|
||||||
January 1, 2020 to January 31, 2020
|
|
706,463
|
|
|
$
|
4.86
|
|
|
706,463
|
|
|
$
|
23,225,251
|
|
February 1, 2020 to February 29, 2020
|
|
56,144
|
|
|
$
|
4.01
|
|
|
56,144
|
|
|
$
|
23,000,379
|
|
March 1, 2020 to March 31, 2020
|
|
165,779
|
|
|
$
|
3.31
|
|
|
165,779
|
|
|
$
|
22,452,355
|
|
Total
|
|
928,386
|
|
|
$
|
4.53
|
|
|
928,386
|
|
|
|
Exhibit
number |
Description
|
10.1
|
|
31.1
|
|
31.2
|
|
32.1&
|
|
32.2&
|
|
101.INS*
|
XBRL Instance Document.
|
101.SCH*
|
XBRL Taxonomy Extension Schema Document.
|
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
101.LAB*
|
XBRL Taxonomy Extension Labels Linkbase Document.
|
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
&
|
|
This certification is deemed not filed for purposes of section 18 of the Securities Exchange Act of 1934, as amended (Exchange Act), or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.
|
*
|
|
Pursuant to applicable securities laws and regulations, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of sections 11 or 12 of the Securities Act, are deemed not filed for purposes of section 18 of the Exchange Act and otherwise are not subject to liability under these sections.
|
|
|
Elevate Credit, Inc.
|
|
|
|
|
|
Date:
|
May 8, 2020
|
By:
|
/s/ Jason Harvison
|
|
|
|
Jason Harvison
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
|
|
|
|
Date:
|
May 8, 2020
|
By:
|
/s/ Christopher Lutes
|
|
|
|
Christopher Lutes
|
|
|
|
Chief Financial Officer
(Principal Financial Officer)
|
|
|
|
|
|
ELEVATE CREDIT, INC.
|
|
|
By:
|
/s/ Jason Harvison
|
Name:
|
Jason Harvison
|
Title:
|
President and CEO
|
|
|
|
ACKNOWLEDGED BY FIRST FINANCIAL LOAN COMPANY LLC:
|
|
|
By:
|
/s/ C Dan Adams
|
|
C Dan Adams
|
|
President and CEO
|
|
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Elevate Credit, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
May 8, 2020
|
By:
|
/s/ Jason Harvison
|
|
|
|
Jason Harvison
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Elevate Credit, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
|
4.
|
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
a.
|
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
b.
|
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
c.
|
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
|
d.
|
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
|
5.
|
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
|
a.
|
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
|
b.
|
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
May 8, 2020
|
By:
|
/s/ Christopher Lutes
|
|
|
|
Christopher Lutes
|
|
|
|
Chief Financial Officer
(Principal Financial Officer)
|
i.
|
The Company’s Quarterly Report on Form 10-Q for the period ending March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
ii.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
May 8, 2020
|
By:
|
/s/ Jason Harvison
|
|
|
|
Jason Harvison
|
|
|
|
Chief Executive Officer
(Principal Executive Officer)
|
i.
|
The Company’s Quarterly Report on Form 10-Q for the period ending March 31, 2020 as filed with the Securities and Exchange Commission on the date hereof (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
ii.
|
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
May 8, 2020
|
By:
|
/s/ Christopher Lutes
|
|
|
|
Christopher Lutes
|
|
|
|
Chief Financial Officer
(Principal Financial Officer)
|